There’s been a lot of talk about how the pandemic has adversely affected people’s sleep. Whether it be from stress, the dreaded “COVID 10” weight gain, or just the disruption in normal patterns, people seem to be having a harder time getting a good night’s rest. ResMed ( NYSE:RMD ) and Fisher & Paykel ( OTC:FSPKF ) are doing something about that and helping their investors rest easier, as well. The companies are among the leading makers of sleep apnea devices, such as continuous positive airway pressure (CPAP) machines. Many medical-device makers’ businesses suffered during the pandemic because not as many people made regular doctor’s office or sleep-center visits, but these two companies still saw their revenues — and stock shares — rise. It’s a very competitive space, with other major players such as Koninklijke Philips Electronics and General Electric also fighting for market share. The growth of sleep apnea products has also caught the attention of medical insurers, which have increasingly passed more of those costs onto consumers due to their concerns about the growing costs associated with sleep apnea care. IMAGE SOURCE: GETTY IMAGES Fisher & Paykel’s investors can breathe easily Fisher & Paykel’s stock is up more… Read full this story
- Social News 13/10
- Beating the odds
- Xiaomi Phone 2 review: high-end specs in a surprisingly affordable package
- No menstrual hygiene for Indian women holds economy back
- How the bank lobby loosened US reins on derivatives
- Art & Entertainment Highlights for November 7
2 Companies Whose Products, and Profits, Could Help You Sleep Better at Night have 241 words, post on www.fool.com at April 14, 2021. This is cached page on Konitono. If you want remove this page, please contact us.